Literature DB >> 25284345

Lipoic acid and lipoic acid analogs in cancer metabolism and chemotherapy.

Paul M Bingham1, Shawn D Stuart, Zuzana Zachar.   

Abstract

The lipoic acid (lipoate) coenzyme is unique in all of mammalian metabolism. It is not only crucial to the function of some of the major enzymes feeding carbon into the tricarboxylic acid cycle, but also generates dynamic regulatory information about the metabolic status of the mitochondrial matrix, ultimately functioning to control these metabolic fluxes. Moreover, these lipoate-sensitive regulatory processes are apparently systematically redesigned in tumor cells and the affected enzymes commonly become especially central to cancer metabolism. Thus, lipoate-sensitive regulatory processes constitute potentially uniquely valuable targets for chemotherapeutic attack. Our goal here is to review the current status of our knowledge relevant to the use of lipoate and lipoate analogs to therapeutically attack malignant disease.

Entities:  

Keywords:  cancer metabolism; chemotherapy; lipoate; lipoate analogs; lipoic acid; lipoic acid analogs; tumor mitochondria; two compartment metabolism

Mesh:

Substances:

Year:  2014        PMID: 25284345     DOI: 10.1586/17512433.2014.966816

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  14 in total

1.  A Phase III open-label trial to evaluate efficacy and safety of CPI-613 plus modified FOLFIRINOX (mFFX) versus FOLFIRINOX (FFX) in patients with metastatic adenocarcinoma of the pancreas.

Authors:  Philip A Philip; Marc E Buyse; Angela T Alistar; Caio MSPR Rocha Lima; Sanjeev Luther; Timothy S Pardee; Eric Van Cutsem
Journal:  Future Oncol       Date:  2019-09-12       Impact factor: 3.404

2.  Specific inhibition by synthetic analogs of pyruvate reveals that the pyruvate dehydrogenase reaction is essential for metabolism and viability of glioblastoma cells.

Authors:  Victoria I Bunik; Artem Artiukhov; Alexey Kazantsev; Renata Goncalves; Danilo Daloso; Henry Oppermann; Elena Kulakovskaya; Nikolay Lukashev; Alisdair Fernie; Martin Brand; Frank Gaunitz
Journal:  Oncotarget       Date:  2015-11-24

3.  Integrated transcriptomic and proteomic analyses reveal ɑ-lipoic acid-regulated cell proliferation via Grb2-mediated signalling in hepatic cancer cells.

Authors:  Lan Yang; Xiliang Wang; Juan Xu; Ya Wen; Manqiao Zhang; Jingxiao Lu; Rongfu Wang; Xiaojuan Sun
Journal:  J Cell Mol Med       Date:  2018-03-25       Impact factor: 5.310

Review 4.  MicroRNAs in Tumor Cell Metabolism: Roles and Therapeutic Opportunities.

Authors:  Abraham Pedroza-Torres; Sandra L Romero-Córdoba; Montserrat Justo-Garrido; Iván Salido-Guadarrama; Rubén Rodríguez-Bautista; Sarita Montaño; Rodolfo Muñiz-Mendoza; Cristian Arriaga-Canon; Verónica Fragoso-Ontiveros; Rosa María Álvarez-Gómez; Greco Hernández; Luis A Herrera
Journal:  Front Oncol       Date:  2019-12-11       Impact factor: 6.244

5.  A Novel Paclitaxel Conjugate with Higher Efficiency and Lower Toxicity: A New Drug Candidate for Cancer Treatment.

Authors:  Mizied Falah; Mahmoud Rayan; Anwar Rayan
Journal:  Int J Mol Sci       Date:  2019-10-08       Impact factor: 5.923

6.  Hyperosmolarity Triggers the Warburg Effect in Chinese Hamster Ovary Cells and Reveals a Reduced Mitochondria Horsepower.

Authors:  Jorgelindo da Veiga Moreira; Lenny De Staercke; Pablo César Martínez-Basilio; Sandrine Gauthier-Thibodeau; Léa Montégut; Laurent Schwartz; Mario Jolicoeur
Journal:  Metabolites       Date:  2021-05-26

7.  The Antioxidant Cofactor Alpha-Lipoic Acid May Control Endogenous Formaldehyde Metabolism in Mammals.

Authors:  Anastasia V Shindyapina; Tatiana V Komarova; Ekaterina V Sheshukova; Natalia M Ershova; Vadim N Tashlitsky; Alexander V Kurkin; Ildar R Yusupov; Garik V Mkrtchyan; Murat Y Shagidulin; Yuri L Dorokhov
Journal:  Front Neurosci       Date:  2017-12-01       Impact factor: 4.677

8.  Inhibition of mitochondrial 2-oxoglutarate dehydrogenase impairs viability of cancer cells in a cell-specific metabolism-dependent manner.

Authors:  Victoria I Bunik; Garik Mkrtchyan; Aneta Grabarska; Henry Oppermann; Danilo Daloso; Wagner L Araujo; Malgorzata Juszczak; Wojciech Rzeski; Lucien Bettendorff; Alisdair R Fernie; Jürgen Meixensberger; Andrzej Stepulak; Frank Gaunitz
Journal:  Oncotarget       Date:  2016-05-03

9.  Untargeted metabolomic on urine samples after α-lipoic acid and/or eicosapentaenoic acid supplementation in healthy overweight/obese women.

Authors:  Ana Romo-Hualde; Ana E Huerta; Carlos J González-Navarro; Omar Ramos-López; María J Moreno-Aliaga; J Alfredo Martínez
Journal:  Lipids Health Dis       Date:  2018-05-09       Impact factor: 3.876

10.  Combining lipoic acid to methylene blue reduces the Warburg effect in CHO cells: From TCA cycle activation to enhancing monoclonal antibody production.

Authors:  Léa Montégut; Pablo César Martínez-Basilio; Jorgelindo da Veiga Moreira; Laurent Schwartz; Mario Jolicoeur
Journal:  PLoS One       Date:  2020-04-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.